1/9/2023 1:35:14 PM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>1/6/2023 12:56:17 PM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>1/5/2023 12:48:24 PM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>12/30/2022 11:58:56 AM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>12/22/2022 1:06:23 PM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>12/21/2022 12:32:05 PM - Quarterly comparisons through Sep &#39;22 showed earnings increases below the +25% minimum guideline (C criteria).<br><hr>10/28/2020 12:58:33 PM - Pulling back abruptly today with higher volume and testing its 50 DMA line ($5.05).  Stalled soon after wedging above previously stubborn resistance in the $5.70 area. Three of the past 4 quarterly comparisons through Jun &#39;20 showed earnings increases above the +25% guideline (C criteria).<br><hr>9/21/2020 12:28:23 PM - Pulling back today with higher volume after challenging previously stubborn resistance in the $5.70 area. Three of the past 4 quarterly comparisons through Jun &#39;20 showed earnings increases above the +25% guideline (C criteria).<br><hr>9/14/2020 12:46:56 PM - Today&#39;s big gain has it rallying toward previously stubborn resistance in the $5.50 to $5.70 area which it met over the past year. Three of the past 4 quarterly comparisons through Jun &#39;20 showed earnings increases above the +25% guideline (C criteria).<br><hr>9/11/2020 12:35:49 PM - Met stubborn resistance in the $5.50 to $5.70 area over the past year. Three of the past 4 quarterly comparisons through Jun &#39;20 showed earnings increases above the +25% guideline (C criteria).<br><hr>